Is AbCellera Biologics Inc. (ABCL) a Buy, Sell, or Hold?
AbCellera Biologics Inc.
NASDAQ:ABCL
$6.74 USD
$0 (0.0%)
- Volume
- 3.72M
- Average Volume
- 8.14M
- Market Capitalization
- $2.06B
- P/E Ratio
- -14.04
- Dividend Yield
- 0.00%
- Price Target
- $7.50
- Year High
- $8.44
- Year Low
- $2.75
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $14.05
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-10.1% DOWNSIDE
$7.50 Price Target
UPSIDE/DOWNSIDE HIGH
-15.8% DOWNSIDE
$8.00 Price Target High
UPSIDE/DOWNSIDE LOW
-3.7% DOWNSIDE
$7.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| BMO Capital | Gary Nachman | $5 | $2.735 | 2024-11-05 08:14 AM | 82.8% |
| KeyBanc | Scott Schoenhaus | $5 | $2.595 | 2024-08-23 07:57 AM | 92.7% |
| KeyBanc | Scott Schoenhaus | $7 | $3.84 | 2024-05-07 10:46 PM | 82.3% |
| Goldman Sachs | Andrea Tan | $30 | $10.13 | 2022-12-14 11:41 PM | 196.2% |